Next Generation Estrogen Receptor Degraders in Patients with Estrogen Receptor Positive (ER+), Human Epidermal Growth Factor Receptor 2-negative (HER2-) Metastatic Breast Cancer with Endocrine Resistance: A Systematic Review, and Meta-Analysis

Authors / 作者群

Tzu-Tung Kan ¹ ; Yen-Shen Lu ²

Affiliation / 服務單位

1.Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan

2.Division of Medical Oncology, Department of Oncology, National Taiwan University Hospital, and National Taiwan University College of Medicine, Taipei, Taiwan

Audio / 音訊檔

Category / 主題分類

Clinical Research

Keyword / 關鍵字

Advanced breast cancer; oral SERDs, PROTAC, ESR1 mutation; endocrine resistance; combination therapy, target therapy, progression-free survival, systematic review, meta-analysis

Back to list